Share new trends in technology and health
The 2020 Expanded Meeting of the Board of Directors of HEC Group was successfully held at the Group Headquarters
2021-01-22
From January 18th to 21st, 2021. the 2020 enlarged meeting of the board of directors of HEC Group was successfully held at the group headquarters (Changan, Dongguan).
Group chairman Zhang Yushuai, group directors Tang Xinfa, Lu Yuxin, Zhu Yingwei, Zhang Hongwei, Deng Xinhua, group supervisors Hu Zhidong, Zhou Lin, Wei Cailiang, and relevant leaders of R&D, production, sales, finance and other fronts attended the meeting.
The enlarged meeting of the board of directors is conducted in the form of industry group discussions, which are divided into four major research groups: electronic materials and chemical industry, pharmaceutical industry, big health industry and financial line. The enlarged meeting fully discusses: the main contradictions faced by the development of various industries and formulate solutions; development plans of various industries in the next 5 years; capital and capital plans for the next 3-5 years; tasks and performance appraisal goals for 2021, The enlarged meeting puts forward work plans, and proposes the support provided by the company level; provides suggestions for corporate governance.
(On-site of electronic materials and chemical industry seminar group)
(On-site of the pharmaceutical industry seminar group)
(On-site of the large health industry seminar group)
(On-site of the financial line seminar group)
During the meeting, the board of directors discussed and reviewed: the implementation of share reform and equity incentive plan; the year-end distribution plan in 2020; organizational construction and advanced commendation and selection; industry development planning, capital and capital planning for the next 3-5 years; tasks and performance in 2021 assessment objectives.
At the meeting, Chairman Zhang Yushuai delivered an important speech:
Looking back on 2020: In the face of the new crown epidemic, we stabilized production, strived for performance, and ensured safety, and at the same time actively contributed to the fight against the epidemic; we turned grief into motivation, worked together with one heart, and worked tenaciously; in the past year, we have withstood the test, resisted the pressure, and the victory belongs to us!
Facing the future, a new starting point and a new journey, we must unswervingly take the road of technological innovation, view and solve problems from a developmental perspective, and reform is for better development.
The company is accelerating the implementation of the share reform policy, and has formulated a long-term and continuous equity incentive plan. Through the share reform and equity incentives, those who have contributed to the company and those who have done well now and in the future will have more gains and work with the company. We share weal and woe together and share results.
Continue to strengthen industry-oriented management, effectively do subtraction, concentrate on doing well and strengthen advantageous industries, and pay more attention to creating profits; strengthen human resource management, optimize performance appraisal and salary distribution systems, and improve the execution of the company's strategic planning; give full play to the industrial advantages, make full use of the market, and through the continuous integration of resources, the financial situation of the group company will be completely improved within three years, and the goal of exceeding the market value of more than 100 billion will be achieved.
Finally, in this era of rapid change, we have the best industry in medicine and health. I believe that under the leadership of the board of directors, we will make every effort to do our best, and work together to practice the mission of "scientific and technological innovation, healthy life" and strive for the great vision of "Centennial HEC"!
(Group photo of directors and supervisors of the group company)
Related news
2021-07-12
WeChat public account
2022 Copyright by HEC Group 粤ICP备19034764号-1
